Regulation and regulatory activities of transforming growth factor beta
- PMID: 10200910
Regulation and regulatory activities of transforming growth factor beta
Abstract
Transforming growth factor beta (TGF beta) is unique among growth factors in its potent and widespread actions. Almost every cell in the body has been shown to make some form of TGF beta, and almost every cell has receptors for TGF beta. Therefore, it becomes apparent that this growth factor must be tightly regulated to prevent disease. The mechanisms of regulation of TGF beta are extensive and complex. One set of mechanisms centers around the fact that TGF beta is produced in a latent form that must be activated to produce biologically active TGF beta. These mechanisms include the latency of the molecule, the production of various latent forms, its targeting to cells for activation or to matrix for storage, and the means of activation of the latent forms. The TGF beta isoforms and the types, affinity, and signaling functions of its receptors also add complexity to the regulation of the effects of TGF beta. Active TGF beta regulates numerous processes in the body. TGF beta has three major biological effects: growth inhibition, stimulation of extracellular matrix formation, and immunosuppression. The means by which TGF beta regulates the expression of the numerous genes on which it has effects are complex and more information is needed. The means by which TGF beta regulates gene expression and the means by which the actions of TGF beta are regulated are addressed in this review.
Similar articles
-
Regulation of transforming growth factor-beta signaling.Mol Cell Biol Res Commun. 2001 Nov;4(6):321-30. doi: 10.1006/mcbr.2001.0301. Mol Cell Biol Res Commun. 2001. PMID: 11703090 Review.
-
Transforming growth factor-beta: a general review.Eur Cytokine Netw. 1996 Sep;7(3):363-74. Eur Cytokine Netw. 1996. PMID: 8954178 Review.
-
Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.Biochem J. 2002 Dec 15;368(Pt 3):683-93. doi: 10.1042/BJ20020949. Biochem J. 2002. PMID: 12223100 Free PMC article.
-
Latency, activation, and binding proteins of TGF-beta.Microsc Res Tech. 2001 Feb 15;52(4):354-62. doi: 10.1002/1097-0029(20010215)52:4<354::AID-JEMT1020>3.0.CO;2-G. Microsc Res Tech. 2001. PMID: 11170294 Review.
-
The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).Calcif Tissue Int. 2002 Jan;70(1):54-65. doi: 10.1007/s002230010032. Epub 2001 Dec 21. Calcif Tissue Int. 2002. PMID: 11907708
Cited by
-
Advances in Skin Substitutes-Potential of Tissue Engineered Skin for Facilitating Anti-Fibrotic Healing.J Funct Biomater. 2015 Jul 9;6(3):547-63. doi: 10.3390/jfb6030547. J Funct Biomater. 2015. PMID: 26184327 Free PMC article. Review.
-
High throughput determination of TGFβ1/SMAD3 targets in A549 lung epithelial cells.PLoS One. 2011;6(5):e20319. doi: 10.1371/journal.pone.0020319. Epub 2011 May 20. PLoS One. 2011. PMID: 21625455 Free PMC article.
-
Transcriptional profiling in the livers of rats after hypobaric hypoxia exposure.PeerJ. 2019 Apr 9;7:e6499. doi: 10.7717/peerj.6499. eCollection 2019. PeerJ. 2019. PMID: 30993032 Free PMC article.
-
Bronchioloalveolar invasion in non-small cell lung cancer is associated with expression of transforming growth factor-β1.World J Surg Oncol. 2013 May 25;11:113. doi: 10.1186/1477-7819-11-113. World J Surg Oncol. 2013. PMID: 23705641 Free PMC article.
-
Non-Canonical (RANKL-Independent) Pathways of Osteoclast Differentiation and Their Role in Musculoskeletal Diseases.Clin Rev Allergy Immunol. 2016 Aug;51(1):16-26. doi: 10.1007/s12016-015-8523-6. Clin Rev Allergy Immunol. 2016. PMID: 26578261 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources